Navigation Links
IDM Pharma Announces Updated Data From Mifamurtide (L-MTP-PE) Compassionate Access Program
Date:5/15/2008

- Data Presented at the 21st Annual Meeting of The American Society of

Pediatric Hematology/Oncology (ASPHO) Meeting -

IRVINE, Calif., May 15 /PRNewswire-FirstCall/ -- IDM Pharma, Inc. (the Company) (Nasdaq: IDMI) today announced the presentation of updated data from a compassionate access program evaluating mifamurtide (L-MTP-PE) in patients with lung metastases as a result of the progression of osteosarcoma, a rare and often fatal bone tumor that typically affects children and young adults. The data show that L-MTP-PE in combination with other therapies is safe, well- tolerated and exhibited signs of disease control.

The compassionate access program provides L-MTP-PE treatment to patients who have either failed or cannot tolerate treatment with existing therapies compared to the Phase 3 pivotal study, which evaluated newly diagnosed patients.

"The results that we have seen to date from the Phase 3 clinical trial in patients with non-metastatic osteosarcoma are being supported in patients with lung metastases as the L-MTP-PE compassionate access experience continues to be encouraging," said Peter Anderson, M.D., Ph.D., principal investigator and professor of pediatrics, Children's Cancer Hospital at The University of Texas M. D. Anderson Cancer Center in Houston. "With a formalized protocol now in place, we can address the increasing number of requests for compassionate access to L-MTP-PE and meet the unmet needs of certain patients by providing this much needed treatment option."

Study design and findings

Twenty-nine high-risk osteosarcoma patients (ages 10 - 21) were enrolled and 27 have been treated with L-MTP-PE in the compassionate access program to date (May 8, 2008). Patients in th
'/>"/>

SOURCE IDM Pharma, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Poniard Pharmaceuticals Licenses Kinase Inhibitors From The Scripps Research Institute
2. Pharmasset Commences Dosing R7128 Cohorts 3 and 4 for the Treatment of Chronic Hepatitis C
3. Alseres Pharmaceuticals Announces 12 Month Interim Results from the Phase I/IIa Cethrin(R) Clinical Trial in Acute Spinal Cord Injury
4. Alpharma Presents Data Addressing Abuse Liability Features, Safety and Efficacy on ALO-01 (EMBEDA(TM)) (morphine sulfate extended-release with sequestered naltrexone hydrochloride) at the American Pain Society Annual Scientific Session
5. Vion Pharmaceuticals Announces Initiation of Clinical Trial of Cloretazine(R) (VNP40101M) in Combination with Cytarabine
6. Arena Pharmaceuticals, Inc. Announces Initiation of Phase 1 Clinical Trial of Drug Candidate Under Partnership with Taisho Pharmaceutical Co., Ltd.
7. Poniard Pharmaceuticals Completes Enrollment of Phase 2 Picoplatin Trial in Colorectal Cancer
8. Cadence Pharmaceuticals Reports First Quarter 2008 Financial Results and Provides Clinical Program Update
9. Alseres Pharmaceuticals Enters Agreement to Amend Cethrin(R) License to Lower Milestone Payments and Royalty Rates
10. Champions Biotechnology and Concordia Pharmaceuticals Complete Service Agreement and Begin Preclinical Evaluation of Oncology Drugs
11. Diplomat Specialty Pharmacy Develops and Launches Best-In-Class Electronic Navigator (eNAV(TM)) Patient Care System
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/4/2015)... , Aug. 4, 2015 HeartWare International, ... of less invasive, miniaturized circulatory support technologies that are ... that its President and Chief Executive Officer, Doug ... Genuity 35th Annual Growth Conference at 8:30 a.m. EDT ... held August 12-13, 2015 at the InterContinental Boston. ...
(Date:8/4/2015)... LOS ANGELES , Aug. 4, 2015 ... the world,s leading provider of diagnostic information services, ... announced acquisition of MemorialCare Health System,s laboratory outreach ... of the transaction, patients and physicians now have ... and network of nearly 200 patient service centers ...
(Date:8/4/2015)... SAN FRANCISCO , Aug. 4, 2015 /PRNewswire/ ... Nicki Vasquez , Ph.D., as vice president ... have a leadership role in the management of ... cancer therapeutics pipeline, including antibody-drug conjugates, bispecific antibodies ... Dr. Vasquez brings more than 22 years of ...
Breaking Medicine Technology:HeartWare Presentation At The Canaccord Genuity 35th Annual Growth Conference To Be Webcast 2Quest Diagnostics Completes Acquisition of MemorialCare Health System's Laboratory Outreach Service Business in Southern California 2Sutro Biopharma Appoints Nicki Vasquez, Ph.D. as VP of Alliance and Project Management 2
... Mass., Jan. 17, 2012  CardioFocus, Inc., developer of ... treatment of atrial fibrillation (AF), announces that a ... Electrophysiology demonstrates the high acute and chronic ... procedure using HeartLight EAS. The study was conducted ...
... Inc. (NYSE Amex: PTN ) announced today ... of non-dilutive funding through the New Jersey Economic Development ... New Jersey net operating losses and research and development ... Palatin Technologies received approximately $637,000 under this program. ...
Cached Medicine Technology:Journal of Cardiovascular Electrophysiology Study Shows Promising Single Ablation Procedure Outcomes With HeartLight EAS for Treatment of Atrial Fibrillation 2Journal of Cardiovascular Electrophysiology Study Shows Promising Single Ablation Procedure Outcomes With HeartLight EAS for Treatment of Atrial Fibrillation 3Journal of Cardiovascular Electrophysiology Study Shows Promising Single Ablation Procedure Outcomes With HeartLight EAS for Treatment of Atrial Fibrillation 4
(Date:8/4/2015)... ... August 04, 2015 , ... Worldwide Power Products acquires new ... its reach in Texas. Effective July 1st of this year, Worldwide Power Products ... With the North Texas acquisition, Worldwide Power Products (“WPP”) now services 1000 ...
(Date:8/4/2015)... ... 2015 , ... Recent studies in the United ... binge drinking among certain populations and specific locations. Researchers, who have ... trends and evidence to help facilitate health care treatment to meet current needs. ...
(Date:8/4/2015)... , ... August 04, 2015 , ... Members receiving care ... care metrics – at a cost that is nine percent lower -- than those ... Blue Shield of New Jersey’s patient-centered programs. , “The promise of patient-centered, or ...
(Date:8/4/2015)... ... August 04, 2015 , ... Buckeye Health ... kindergarten. All required immunizations are covered for members under the Healthchek program . ... aren’t caught up with their immunizations may not be allowed to attend when ...
(Date:8/4/2015)... , ... August 04, 2015 , ... ... manufacturing, label design, product packaging, and fulfillment services, joined over 200 other Long ... event was held on Tuesday, July 28th at Jones Beach State Park in ...
Breaking Medicine News(10 mins):Health News:North Texas Acquisition Press Release 2Health News:DARA Responds To International Trends in Binge Drinking 2Health News:DARA Responds To International Trends in Binge Drinking 3Health News:Horizon BCBSNJ: 2014 Results Show Patient-Centered Care Continues to Deliver on Promise of Better Quality Care at a Lower Cost 2Health News:Horizon BCBSNJ: 2014 Results Show Patient-Centered Care Continues to Deliver on Promise of Better Quality Care at a Lower Cost 3Health News:Buckeye Health Plan Reminds Parents to Keep Immunizations In Mind As School Year Kicks Off 2Health News:NutraScience Labs "Steps Up" to the 2015 Marcum Workplace Challenge 2
... available in Spanish . , The ... Clinical Research of European Legislation ) a project with ... the European Directive on Clinical Trials (2001/20/EC) in all ... also has the active participation of the different stakeholders: ...
... public policy effort to boost safety , , MONDAY, July 28 ... in your town or your route to work through an ... of the need to drive safely. , Researchers at ... (CERS) developed www.saferoadmaps.org, so you can simply enter your address ...
... launches new website offering convenient http://www.terrimilen.com [Online Counseling via ... comfort of their own home or office. , ... ... provide clients with an alternative to traditional therapy which requires clients ...
... sample traced back to Mexican farm, FDA announces ... a week after uncovering the first big clue in ... that tainted jalapeno peppers had been definitively traced to ... Drug Administration gave the all-clear to jalapeno and serrano ...
... to discuss second quarter financial results -, LAVAL, ... DDSS) today announced that it will host a conference ... discuss its second quarter 2008,financial results. Labopharm will report ... approximately 7:00 a.m. the same day., To access ...
... function, increases asthma risk, studies find, , , FRIDAY, July ... actually be bad for your health, depending on what ... , Recent research suggests that exposure to cleaning products ... compound (VOC) called 1,4 dicholorobenzene (1,4 DCB), can reduce ...
Cached Medicine News:Health News:Researchers Map America's Deadliest Roads 2Health News:Online Counseling and Life Coaching Practice Launches New Website 2Health News:Mexican Peppers ID'd as Salmonella Culprits 2Health News:Mexican Peppers ID'd as Salmonella Culprits 3Health News:Labopharm to host conference call Friday, August 8, 2008 at 8:30 A.M. (ET) 2Health News:Health Hazards in Household Cleaners Exposed 2Health News:Health Hazards in Household Cleaners Exposed 3
... designed for the retraction of nerves, ... Reduced obstruction when working within a ... of blade sizes from 2 mm ... and release, malleable material allows preferred ...
Telescopic Diamond-Dissectors for delicate sharp tissue preparation. Total/working lengths 220/240 mm with protective sleeve....
Cobb Spinal Curettes, tip size 13.00 mm, length 11" (279 mm)....
Scoville Ruptured Disc Curettes, length 10" (254 mm), cup size 4 x 10 mm....
Medicine Products: